Literature DB >> 27428340

[Current status of alternative therapies renal function at the Instituto Mexicano del Seguro Social].

Antonio Méndez-Durán1, Manuel Humberto Ignorosa-Luna, Gilberto Pérez-Aguilar, Francisco Jesús Rivera-Rodríguez, José Jesús González-Izquierdo, Javier Dávila-Torres.   

Abstract

BACKGROUND: The IMSS performs systematically the data updating of patients with renal replacement therapy (RRT) by an electronic record management referred as: Census patients with Chronical Renal Failure (CIRC) which aims to meet the prevalence of patients with chronic renal failure and the behavior of RRTat the IMSS.
METHODS: A retrospective study includes 212 secondary hospitals with dialysis programs, with both pediatric and adult patients. CIRC data obtained from January to December 2014, number and nominal bonds of peritoneal dialysis (PD) and hemodialysis (HD). Prevalence of patients and therapies by delegation, distribution by gender and age, cause of kidney disease, morbidity and mortality were identified.
RESULTS: 55,101 patients, of whom 29,924 were male (54 %) and 25,177 women (46 %), mean age was 62.1 years (rng: 4-90); 20,387 were pensioners (36.9 %). The causes of renal failure were: diabetes 29,054 (52.7 %), hypertension 18,975 (34.4 %), chronic glomerulopathies 3,951 (7.2 %), polycystic kidneys 1,142 (2.1 %), congenital 875 (1.6 %) and other 1,104 (2 %). HD was given in 41 % of patients, and the remaining 59 % DP; the annual cost was 5,608,290,622 pesos.
CONCLUSIONS: The increased prevalence of diabetes mellitus and hypertension affect the onset of RRT, which show a catastrophic financial outlook for the Institute.

Entities:  

Keywords:  Health programs and plans; Kidney diseases; Mexico; Renal dialysis; Renal replacement therapy

Mesh:

Year:  2016        PMID: 27428340

Source DB:  PubMed          Journal:  Rev Med Inst Mex Seguro Soc        ISSN: 0443-5117


  8 in total

Review 1.  Considerations on equity in management of end-stage kidney disease in low- and middle-income countries.

Authors:  Wim Van Biesen; Vivekanand Jha; Ali K Abu-Alfa; Sharon P Andreoli; Gloria Ashuntantang; Bassam Bernieh; Edwina Brown; Yuqing Chen; Rosanna Coppo; Cecile Couchoud; Brett Cullis; Walter Douthat; Felicia U Eke; Brenda Hemmelgarn; Fan Fan Hou; Nathan W Levin; Valerie A Luyckx; Rachael L Morton; Mohammed Rafique Moosa; Fliss E M Murtagh; Marie Richards; Eric Rondeau; Daniel Schneditz; Kamal D Shah; Vladimir Tesar; Karen Yeates; Guillermo Garcia Garcia
Journal:  Kidney Int Suppl (2011)       Date:  2020-02-19

2.  Global Dialysis Perspective: Mexico.

Authors:  Enzo Vasquez-Jimenez; Magdalena Madero
Journal:  Kidney360       Date:  2020-04-20

3.  [Empowerment and social support for patients with chronic kidney disease: case study in Michoacán, MexicoEmpoderamento e apoio social de pacientes com nefropatia crônica: estudo de caso em Michoacán, México].

Authors:  María Fernanda Carrillo Vega; Blanca Estela Pelcastre Villafuerte; Guillermo Salinas Escudero; Luis Durán Arenas; Y Malaquías López Cervantes
Journal:  Rev Panam Salud Publica       Date:  2017-12-12

Review 4.  TRPV1: Structure, Endogenous Agonists, and Mechanisms.

Authors:  Miguel Benítez-Angeles; Sara Luz Morales-Lázaro; Emmanuel Juárez-González; Tamara Rosenbaum
Journal:  Int J Mol Sci       Date:  2020-05-12       Impact factor: 5.923

Review 5.  Challenges for sustainable end-stage kidney disease care in low-middle-income countries: the problem of the workforce.

Authors:  Charles R Swanepoel; Mignon I McCulloch; Georgi Abraham; Jo-Ann Donner; Mona N Alrukhaimi; Peter G Blake; Sakarn Bunnag; Stefaan Claus; Gavin Dreyer; Mohammad A Ghnaimat; Fuad M Ibhais; Adrian Liew; Marla McKnight; Yewondwossen Tadesse Mengistu; Saraladevi Naicker; Abdou Niang; Gregorio T Obrador; Jeffrey Perl; Harun Ur Rashid; Marcello Tonelli; Kriang Tungsanga; Tushar Vachharajani; Elena Zakharova; Carlos Zuniga; Fredric O Finkelstein
Journal:  Kidney Int Suppl (2011)       Date:  2020-02-19

6.  Socio-demographic and clinical characteristics of type 1 diabetes patients associated with emergency room visits and hospitalizations in Mexico.

Authors:  Svetlana V Doubova; Aldo Ferreira-Hermosillo; Ricardo Pérez-Cuevas; Casper Barsoe; Erick Gryzbowski-Gainza; Juan E Valencia
Journal:  BMC Health Serv Res       Date:  2018-08-03       Impact factor: 2.655

7.  Cost-effectiveness of the use of the continuous subcutaneous insulin infusion pump versus daily multiple injections in type 1 diabetes adult patients at the Mexican Institute of Social Security.

Authors:  Svetlana V Doubova; Stephane Roze; Aldo Ferreira-Hermosillo; Ricardo Pérez-Cuevas; Ricardo Gasca-Pineda; Casper Barsoe; Jonathan Baran; Brian Ichihara; Erick Gryzbowski; Kyla Jones; Juan E Valencia
Journal:  Cost Eff Resour Alloc       Date:  2019-09-03

8.  Application of machine learning methodology to assess the performance of DIABETIMSS program for patients with type 2 diabetes in family medicine clinics in Mexico.

Authors:  Yue You; Svetlana V Doubova; Diana Pinto-Masis; Ricardo Pérez-Cuevas; Víctor Hugo Borja-Aburto; Alan Hubbard
Journal:  BMC Med Inform Decis Mak       Date:  2019-11-12       Impact factor: 2.796

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.